Annual CFF
$34.23 M
+$11.05 M+47.65%
December 31, 2023
Summary
- As of February 7, 2025, JAGX annual cash flow from financing activities is $34.23 million, with the most recent change of +$11.05 million (+47.65%) on December 31, 2023.
- During the last 3 years, JAGX annual CFF has risen by +$14.73 million (+75.60%).
- JAGX annual CFF is now -22.10% below its all-time high of $43.94 million, reached on December 31, 2021.
Performance
JAGX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$3.53 M
-$9.04 M-71.93%
September 30, 2024
Summary
- As of February 7, 2025, JAGX quarterly cash flow from financing activities is $3.53 million, with the most recent change of -$9.04 million (-71.93%) on September 30, 2024.
- Over the past year, JAGX quarterly CFF has dropped by -$9.04 million (-71.93%).
- JAGX quarterly CFF is now -88.56% below its all-time high of $30.87 million, reached on March 31, 2021.
Performance
JAGX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$39.02 M
+$2.12 M+5.75%
September 30, 2024
Summary
- As of February 7, 2025, JAGX TTM cash flow from financing activities is $39.02 million, with the most recent change of +$2.12 million (+5.75%) on September 30, 2024.
- Over the past year, JAGX TTM CFF has increased by +$2.12 million (+5.75%).
- JAGX TTM CFF is now -25.67% below its all-time high of $52.50 million, reached on June 30, 2021.
Performance
JAGX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
JAGX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +47.6% | -71.9% | +5.8% |
| 3 y3 years | +75.6% | +5.2% | +14.9% |
| 5 y5 years | +39.4% | +5.2% | +14.9% |
JAGX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -22.1% | +47.6% | -81.2% | +150.5% | -11.2% | +162.1% |
| 5 y | 5-year | -22.1% | +75.6% | -88.6% | +846.4% | -25.7% | +186.0% |
| alltime | all time | -22.1% | +547.9% | -88.6% | +387.4% | -25.7% | +2719.5% |
Jaguar Health Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $3.53 M(-71.9%) | $39.02 M(+5.7%) |
| Jun 2024 | - | $12.57 M(+2.5%) | $36.90 M(+33.3%) |
| Mar 2024 | - | $12.27 M(+15.2%) | $27.68 M(-19.1%) |
| Dec 2023 | $34.23 M(+47.7%) | $10.65 M(+655.9%) | $34.23 M(+35.7%) |
| Sep 2023 | - | $1.41 M(-58.0%) | $25.21 M(-25.7%) |
| Jun 2023 | - | $3.36 M(-82.2%) | $33.95 M(+0.3%) |
| Mar 2023 | - | $18.81 M(+1048.4%) | $33.84 M(+46.0%) |
| Dec 2022 | $23.18 M(-47.2%) | $1.64 M(-83.9%) | $23.18 M(-6.0%) |
| Sep 2022 | - | $10.15 M(+212.6%) | $24.66 M(+65.6%) |
| Jun 2022 | - | $3.25 M(-60.2%) | $14.89 M(-29.8%) |
| Mar 2022 | - | $8.15 M(+161.1%) | $21.22 M(-51.7%) |
| Dec 2021 | $43.94 M(+125.4%) | $3.12 M(+736.7%) | $43.94 M(-14.9%) |
| Sep 2021 | - | $373.00 K(-96.1%) | $51.62 M(-1.7%) |
| Jun 2021 | - | $9.57 M(-69.0%) | $52.50 M(+8.6%) |
| Mar 2021 | - | $30.87 M(+185.8%) | $48.34 M(+148.0%) |
| Dec 2020 | $19.49 M(-10.5%) | $10.80 M(+762.1%) | $19.49 M(+42.9%) |
| Sep 2020 | - | $1.25 M(-76.9%) | $13.64 M(-36.2%) |
| Jun 2020 | - | $5.41 M(+167.6%) | $21.39 M(+5.2%) |
| Mar 2020 | - | $2.02 M(-59.2%) | $20.33 M(-6.6%) |
| Dec 2019 | $21.77 M | $4.95 M(-45.0%) | $21.77 M(-7.6%) |
| Sep 2019 | - | $9.00 M(+107.1%) | $23.56 M(+50.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | $4.35 M(+25.3%) | $15.69 M(+38.3%) |
| Mar 2019 | - | $3.47 M(-48.6%) | $11.34 M(-53.8%) |
| Dec 2018 | $24.55 M(+129.8%) | $6.74 M(+499.5%) | $24.55 M(+5.9%) |
| Sep 2018 | - | $1.12 M(>+9900.0%) | $23.17 M(-5.8%) |
| Jun 2018 | - | $0.00(-100.0%) | $24.59 M(-9.9%) |
| Mar 2018 | - | $16.68 M(+210.6%) | $27.30 M(+155.7%) |
| Dec 2017 | $10.68 M(+102.2%) | $5.37 M(+110.9%) | $10.68 M(+59.4%) |
| Sep 2017 | - | $2.55 M(-6.1%) | $6.70 M(+25.8%) |
| Jun 2017 | - | $2.71 M(+5046.3%) | $5.32 M(+284.7%) |
| Mar 2017 | - | $52.70 K(-96.2%) | $1.38 M(-73.8%) |
| Dec 2016 | $5.28 M(-78.1%) | $1.39 M(+18.4%) | $5.28 M(+44.9%) |
| Sep 2016 | - | $1.17 M(-195.4%) | $3.65 M(-56.2%) |
| Jun 2016 | - | -$1.23 M(-131.1%) | $8.33 M(-69.0%) |
| Mar 2016 | - | $3.95 M(-1680.6%) | $26.88 M(+11.2%) |
| Dec 2015 | $24.17 M(+297.9%) | -$250.00 K(-104.3%) | $24.17 M(-4.6%) |
| Sep 2015 | - | $5.86 M(-66.2%) | $25.34 M(+35.4%) |
| Jun 2015 | - | $17.32 M(+1297.1%) | $18.71 M(+609.2%) |
| Mar 2015 | - | $1.24 M(+34.8%) | $2.64 M(-56.6%) |
| Dec 2014 | $6.07 M | $920.00 K(-218.8%) | $6.07 M(+17.8%) |
| Sep 2014 | - | -$774.10 K(-161.8%) | $5.15 M(-13.1%) |
| Jun 2014 | - | $1.25 M(-73.2%) | $5.93 M(+26.8%) |
| Mar 2014 | - | $4.68 M | $4.68 M |
FAQ
- What is Jaguar Health annual cash flow from financing activities?
- What is the all time high annual CFF for Jaguar Health?
- What is Jaguar Health annual CFF year-on-year change?
- What is Jaguar Health quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Jaguar Health?
- What is Jaguar Health quarterly CFF year-on-year change?
- What is Jaguar Health TTM cash flow from financing activities?
- What is the all time high TTM CFF for Jaguar Health?
- What is Jaguar Health TTM CFF year-on-year change?
What is Jaguar Health annual cash flow from financing activities?
The current annual CFF of JAGX is $34.23 M
What is the all time high annual CFF for Jaguar Health?
Jaguar Health all-time high annual cash flow from financing activities is $43.94 M
What is Jaguar Health annual CFF year-on-year change?
Over the past year, JAGX annual cash flow from financing activities has changed by +$11.05 M (+47.65%)
What is Jaguar Health quarterly cash flow from financing activities?
The current quarterly CFF of JAGX is $3.53 M
What is the all time high quarterly CFF for Jaguar Health?
Jaguar Health all-time high quarterly cash flow from financing activities is $30.87 M
What is Jaguar Health quarterly CFF year-on-year change?
Over the past year, JAGX quarterly cash flow from financing activities has changed by -$9.04 M (-71.93%)
What is Jaguar Health TTM cash flow from financing activities?
The current TTM CFF of JAGX is $39.02 M
What is the all time high TTM CFF for Jaguar Health?
Jaguar Health all-time high TTM cash flow from financing activities is $52.50 M
What is Jaguar Health TTM CFF year-on-year change?
Over the past year, JAGX TTM cash flow from financing activities has changed by +$2.12 M (+5.75%)